EFFICACE, FABIO
 Distribuzione geografica
Continente #
EU - Europa 10.261
NA - Nord America 478
AS - Asia 112
OC - Oceania 15
AF - Africa 2
SA - Sud America 1
Totale 10.869
Nazione #
IT - Italia 10.106
US - Stati Uniti d'America 470
SE - Svezia 59
CN - Cina 41
SG - Singapore 40
UA - Ucraina 35
DE - Germania 20
KR - Corea 18
FI - Finlandia 16
AU - Australia 15
GB - Regno Unito 9
CA - Canada 8
BE - Belgio 5
AT - Austria 4
VN - Vietnam 4
FR - Francia 2
HK - Hong Kong 2
JP - Giappone 2
NL - Olanda 2
TN - Tunisia 2
TW - Taiwan 2
BO - Bolivia 1
ES - Italia 1
HR - Croazia 1
IE - Irlanda 1
IN - India 1
MY - Malesia 1
PH - Filippine 1
Totale 10.869
Città #
Cagliari 9.626
Uta 395
Fairfield 71
Ashburn 51
Boardman 49
Nyköping 45
Chandler 34
Woodbridge 31
Cambridge 28
Singapore 28
Houston 26
Wilmington 25
Seattle 24
Shanghai 22
New York 21
Ann Arbor 20
Rome 19
Seoul 18
Helsinki 15
Sydney 12
Milan 11
San Diego 6
Toronto 6
Boston 4
Dearborn 4
Dong Ket 4
Jacksonville 4
Palermo 4
Adelaide 3
Andover 3
Bielefeld 3
Innsbruck 3
Redwood City 3
Beijing 2
Bologna 2
Borgomanero 2
Brussels 2
Elmas 2
Florence 2
Fremont 2
Guangzhou 2
Hong Kong 2
Lissone 2
London 2
Montréal 2
Neustadt an der Weinstraße 2
Sassari 2
Sousse 2
Taichung 2
Verolanuova 2
Zhengzhou 2
Zottegem 2
Abano Terme 1
Auburn 1
Casalgrande 1
Chiswick 1
Clifton 1
Dublin 1
Düsseldorf 1
Enschede 1
Gurugram 1
Helmond 1
Hounslow 1
Kilburn 1
Krefeld 1
Kuala Lumpur 1
Kunming 1
Los Angeles 1
Nanjing 1
Paris 1
Philadelphia 1
Portland 1
Prescot 1
Quartu Sant'elena 1
Redmond 1
San Marcellino 1
San Mateo 1
San Sperate 1
Santa Cruz 1
Santa Maria 1
Sardara 1
Tokyo 1
Tortona 1
Vienna 1
Welle 1
Wuhan 1
Totale 10.690
Nome #
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis 1.976
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors 1.445
Thresholds for clinical importance were defined for the EORTC CAT Core - an adaptive measure of core quality of life domains in oncology clinical practice and research 1.421
Low low-density lipoprotein (LDL), cholesterol and triglycerides plasma levels are associated with reduced risk of arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life. A Campus CML study 1.347
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index 989
Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical Trials 576
Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation 535
Long-term health-related quality of life in patients with beta-thalassemia after unrelated hematopoietic stem cell transplantation 501
Patient-Reported Outcomes in Randomized Controlled Trials of Patients with Multiple Myeloma: A Systematic Literature Review of Studies Published Between 2014 and 2021 415
International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia 398
Physicians’ Perceptions of Clinical Utility of a Digital Health Tool for Electronic Patient-Reported Outcome Monitoring in Real-Life Hematology Practice. Evidence From the GIMEMA-ALLIANCE Platform 325
Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after Splenectomy 313
International validation of two EORTC questionnaires for assessment of health‐related quality of life for patients with high‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐HG29) and low‐grade non‐Hodgkin lymphoma (QLQ‐NHL‐LG20) 264
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study 233
Long-term health-related quality of life and mental health in patients with immune thrombotic thrombocytopenic purpura 117
Response to Dr. Ying Cui comments 75
Totale 10.930
Categoria #
all - tutte 14.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020595 0 0 0 7 129 152 149 32 31 20 12 63
2020/20213.316 79 148 134 961 643 385 230 182 67 247 164 76
2021/20221.316 76 82 48 47 81 105 71 65 161 176 202 202
2022/20231.810 118 194 273 103 157 177 85 158 108 127 189 121
2023/20242.176 78 69 143 253 182 364 308 149 116 133 162 219
2024/20251.717 419 577 584 137 0 0 0 0 0 0 0 0
Totale 10.930